IPO
PE-backed InnoCare raises $288m in Hong Kong IPO
InnoCare Pharma, a private equity-backed Chinese drug developer focused on treatments for cancer and autoimmune diseases, has raised HK$2.24 billion ($288 million) through a Hong Kong IPO.
Carlyle secures partial exit from India's SBI Cards
The Carlyle Group has generated proceeds of approximately INR70.3 billion ($951 million) through a partial exit from SBI Cards & Payments, the State Bank of India's (SBI) credit card issuing arm, through a recent IPO.
Australia IPOs: Suspicious minds
A handful of bad experiences have made Australia’s public market investors wary of private equity-backed IPOs. This doesn’t mean offerings can’t get done, but the industry must address its profile problem
India's Barbeque Nation re-files for IPO
Indian restaurant chain Barbeque Nation has re-filed for an initial public offering that will provide an exit opportunity for its private equity investors.
PE-backed SBI Cards wins approval for India IPO
SBI Cards and Payments, the State Bank of India's (SBI) credit card arm and a Carlyle Group portfolio company, is looking to raise INR60 billion ($840 million) through a domestic IPO.
Japanese advisor matching network set for $54m IPO
VisasQ, a Japanese matchmaking platform that connects companies with relevant advisors, is looking to raise approximately JPY5.97 billion ($54 million) through a Tokyo IPO that will provide partial exits for several VC backers.
PE-backed Akeso Biopharma targets Hong Kong IPO
Chinese biotech player Akeso Biopharma has made a second attempt at filing for a Hong Kong IPO after its previous application was rejected last month for failing to meet regulatory requirements.
Advantage-owned Japanese funeral services business to go public
Advantage Partners is set to make a partial exit from Kizuna Holdings Corporation, a Japanese funeral services business it acquired for around JPY2 billion ($18 million) in 2016, through an IPO.
AVCJ Awards 2019: Firm of the Year - Mid Cap: Centurium Capital
China-focused Centurium Capital has enjoyed a productive 12 months, closing its debut US dollar fund, deploying most of the capital, and securing an early liquidity event
CITIC Capital targets OBOR deals with blank check company
CITIC Capital has launched a special purpose acquisition vehicle (SPAC) – or blank check company – on the New York Stock Exchange to pursue deals under its One Belt One Road (OBOR) strategy.
AVCJ Awards 2019: Exit of the Year - IPO: Innovent Biologics
Innovent Biologics has set a new standard for Chinese biotech, securing an innovative drug development tie-up with Eli Lilly and then completing a successful Hong Kong listing
China's Danke raises $130m in scaled back IPO
Chinese apartment rental platform Danke raised about $130 million in a smaller-than-expected US IPO that was primarily underwritten by existing private equity investors.
Asia PE fundraising falls 28% in 2019
Capital committed to Asia-focused private equity managers fell 28% year-on-year to $104.4 billion in 2019, largely due to a drop-off in activity in the pan-regional buyout and venture capital segments. Investments and exits were also down on the previous...
China's I-Mab falls on US debut after $104m IPO
China-based I-Mab Biopharma traded as much as 12% lower than initial pricing following the private equity-backed company’s $104 million IPO in the US.
China Feihe gains drive Morgan Stanley's investment revenue
Projected carried interest payments from Morgan Stanley Private Equity Asia’s (MSPEA) investment in Chinese dairy products company China Feihe were largely responsible for a near fivefold increase in annual investment revenue for the parent bank.
Timeline: 2019 by numbers
A selection of the key fundraising, investment and exit events - presented in chronological order - from the past 12 months
China's largest co-working player Ucommune files for US IPO
Ucommune, China’s largest co-working space player which is considered the local equivalent to troubled US operator WeWork, has filed for a US IPO.
Chinese drone maker EHang raises $40m in US IPO
Chinese drone manufacturer EHang traded flat on its NASDAQ debut following a $40 million IPO that priced at the bottom end of the indicative range.
2019 in review: Falling short
Fundraising, investment and exits in Asia are unlikely to match last year as pan-regional funds take a back seat, large-cap buyouts remain in short supply, growth-stage tech loses its edge, and IPOs flounder
China's Genetron secures $50m Series D, seeks US IPO
Genetron Holdings, a precision oncology technology developer in China, has raised a $50 million Series D round and filed for a US IPO.
Chinese bitcoin player completes $90m IPO, endures bumpy debut
Chinese bitcoin mining equipment manufacturer Canaan experienced a volatile first day of trading on NASDAQ after raising $90 million in a smaller-than-expected IPO.
Japanese space rental platform files for IPO
SpaceMarket, a Japanese start-up that lists vacant spaces available for rent for corporate events, is looking to raise up to JPY933.2 million ($8.5 million) through a domestic IPO.
PE-backed Chinese SaaS player pursues US IPO
CDP, a Chinese human resources software-as-a-service (SaaS) platform that counts NASDAQ-listed 51job and China Broadband Capital (CBC) as its largest external investors, has filed for an IPO in the US.
PE-backed Ping An fintech spin-out pursues US offering
OneConnect Financial Technology, an affiliate of China’s Ping An Insurance backed by the likes of IDG Capital, SBI Group, and SoftBank Vision Fund, has filed to list in the US.